100 Recruiting Studies Using Carboplatin

Active clinical trials that use this intervention, sourced directly from the NIH registry.

Browse by condition

Trials Using Carboplatin

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska

Anal Basaloid Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer

📍 M D Anderson Cancer Center — Houston, Texas

Metastatic Lung Non-Small Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

📍 University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona

Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

📍 M D Anderson Cancer Center — Houston, Texas

Squamous Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

📍 Brigham and Women's Hospital — Boston, Massachusetts

Salivary Gland Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

📍 Indiana University — Indianapolis, Indiana

Carcinoma Breast Stage IV

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

📍 University of Chicago — Chicago, Illinois

Human Papilloma Virus

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

📍 City of Hope Corona — Corona, California

FIGO Stage IVA Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

📍 Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital — Marietta, Georgia

Small-Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Observational / Diagnostic 💊 Investigational Drug / Biologic

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Stage IB Lung Non-Small Cell Carcinoma AJCC v7

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

📍 Kaiser Permanente - Oakland ( Site 0054) — Oakland, California

Non-small Cell Lung Cancer (NSCLC)

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Borderline Ovarian Mucinous Tumor

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Limited Stage Lung Small Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

📍 Research Site — Orlando, Florida

Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)

📍 M D Anderson Cancer Center — Houston, Texas

Stage III Fallopian Tube Cancer AJCC v7

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

📍 Research Site — Foothill Ranch, California

Advanced Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska

Metastatic Cholangiocarcinoma

View Study & Checklist ➔

ACTIVE_NOT_RECRUITING Phase3 💊 Investigational Drug / Biologic

A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

📍 City of Hope 2 — Duarte, California

Carcinoma, Non-Small-Cell Lung

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

📍 Moffitt Cancer Center-International Plaza — Tampa, Florida

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

📍 GSK Investigational Site — Goodyear, Arizona

Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

📍 HonorHealth Research Institute — Scottsdale, Arizona

Solid Tumor

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

📍 Southern Cancer Care — Daphne, Alabama

NSCLC

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

📍 Research Site — Duarte, California

Non-Small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC

📍 Research Site — Iowa City, Iowa

Metastatic Non-Small Cell Lung Cancer (NSCLC)

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

📍 Los Angeles General Medical Center — Los Angeles, California

Metastatic Lung Non-Small Cell Squamous Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer

📍 Froedtert Hospital & Medical College of Wisconsin — Milwaukee, Wisconsin

Invasive Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Fallopian Tube Clear Cell Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

📍 M D Anderson Cancer Center — Houston, Texas

Breast Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line

📍 Canberra Hospital — Garran,

Endometrial Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

MPDL3280A With Chemoradiation for Lung Cancer

📍 MD Anderson Cancer Center — Houston, Texas

Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

📍 Research Site — Tucson, Arizona

Endometrial Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

📍 Research Site — Santa Rosa, California

Unresectable Pleural Mesothelioma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona

Metastatic Fallopian Tube Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

📍 Washington University School of Medicine — St Louis, Missouri

Esophagus Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

📍 Research Site — Duarte, California

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

📍 Innovative Clinical Research Institute — Whittier, California

Non-small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania

Esophageal Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

📍 Research Site — Columbus, Georgia

Non Small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

📍 Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd — Tucson, Arizona

Triple Negative Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer

📍 Johns Hopkins University — Baltimore, Maryland

Gastric Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

📍 Beverly Hills Cancer Center — Beverly Hills, California

Locally Advanced Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Early Phase1 💊 Investigational Drug / Biologic

A Study of N9 Chemotherapy in Children With Neuroblastoma

📍 Memorial Sloan Kettering Cancer Center — New York, New York

Neuroblastoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

📍 Clermont Oncology Center — Clermont, Florida

Resectable Non-small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

📍 Local Institution - 0104 — Tampa, Florida

Carcinoma, Non-Small-Cell Lung

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

'ADVANCE' (A Pilot Trial)

📍 City of Hope National Medical Center — Duarte, California

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

📍 M D Anderson Cancer Center — Houston, Texas

Aggressive Variant Prostate Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

📍 UCSF Medical Center-Mission Bay — San Francisco, California

Fallopian Tube Endometrioid Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

📍 Cohen Children's Medical Center of New York — New Hyde Park, New York

Pilomyxoid Astrocytoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

📍 Kingman Regional Medical Center — Kingman, Arizona

Gastric Neuroendocrine Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska

Malignant Solid Tumor

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

📍 City of Hope National Medical Center — Long Beach, California

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

📍 University of Miami — Miami, Florida

Neuroendocrine Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

📍 Children's Hospital of Alabama — Birmingham, Alabama

Ganglioneuroblastoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Resectable Lung Non-Small Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

HOT: HIPEC in Ovarian Cancer as Initial Treatment

📍 Mercy Medical Center — Baltimore, Maryland

Stage III Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California

Anatomic Stage II Breast Cancer AJCC v8

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

📍 University of Alabama at Birmingham — Birmingham, Alabama

Carcinoma, Non-Small-Cell Lung

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey

Estrogen Receptor-negative Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

📍 University of Arizona Cancer Center /ID# 268906 — Tucson, Arizona

High Grade Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer

📍 University of Illinois — Chicago, Illinois

Triple Negative Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

📍 Research Site — Birmingham, Alabama

Unresectable Locally Advanced Urothelial Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study of AZD2811 + Durvalumab in ES-SCLC

📍 Research Site — Grand Rapids, Michigan

Small-Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama

Lung Non-Squamous Non-Small Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Observational / Diagnostic 💊 Investigational Drug / Biologic

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

📍 Jonsson Comprehensive Cancer Center — Los Angeles, California

Adenocarcinoma of the Lung

View Study & Checklist ➔

ACTIVE_NOT_RECRUITING phase2 Protocol

Volrustomig Priming Regimens Exploratory Phase II Platform Study

📍 Research Site — Los Angeles, California

Non-small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

📍 Research Site — Phoenix, Arizona

NSCLC

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

📍 Research Site — La Jolla, California

Advanced or Metastatic NSCLC

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

📍 Research Site — Daphne, Alabama

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer

📍 Princess Margaret Cancer Centre — Toronto, Ontario

Recurrent Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

📍 City of Hope Comprehensive Cancer Center — Duarte, California

Advanced Esophageal Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

📍 City of Hope Medical Center — Duarte, California

Extensive Stage Lung Small Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

📍 HonorHealth-USOR HonorHealth ( Site 8000) — Phoenix, Arizona

Endometrial Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

📍 Infirmary Cancer Care ( Site 0022) — Mobile, Alabama

Small Cell Lung Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

📍 Saint Joseph's Hospital and Medical Center — Phoenix, Arizona

Endometrial Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

📍 University of Alabama Birmingham — Birmingham, Alabama

Epithelial Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

📍 Clearview Cancer Institute — Huntsville, Alabama

Lung Cancer, Non-squamous, Non-small Cell

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

📍 Honor Health — Phoenix, Arizona

Carcinoma, Ovarian Epithelial

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)

📍 Alaska Oncology and Hematology, LLC. — Anchorage, Alaska

Non-small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

📍 Washington University School of Medicine, Siteman Cancer Center — St Louis, Missouri

Diffuse Large B-cell-lymphoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial

📍 M D Anderson Cancer Center — Houston, Texas

Extensive Stage Lung Small Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

📍 University of Alabama - Birmingham ( Site 3061) — Birmingham, Alabama

Endometrial Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

📍 Comprehensive Blood and Cancer Center — Bakersfield, California

Thoracic Tumors

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

📍 Ironwood Cancer & Research Centers - Chandler — Chandler, Arizona

Urothelial Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab

📍 UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California

Breast Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

📍 Research Site — Birmingham, Alabama

Small Cell Lung Carcinoma Extensive Disease

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

APG-115 in Salivary Gland Cancer Trial

📍 Moffitt Cancer Center — Tampa, Florida

Malignant Salivary Gland Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

📍 Wake Forest Baptist Health Sciences — Winston-Salem, North Carolina

Head Neck Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01

📍 Siteman Cancer Center — St Louis, Missouri

Head and Neck Squamous Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL

📍 City of Hope Medical Center — Duarte, California

Recurrent Hodgkin Lymphoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

📍 Rush University Medical Center — Chicago, Illinois

Carcinoma, Non-Small-Cell Lung

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer

📍 University of Texas MD Anderson Cancer Center — Houston, Texas

Advanced Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Prostate Cancer Biomarker Enrichment and Treatment Selection

📍 Cross Cancer Institute — Edmonton, Alberta

Prostate Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC

📍 Holden Comprehensive Cancer Cener — Iowa City, Iowa

Carcinoma, Non-Small-Cell Lung

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

📍 Mayo Clinic — Scottsdale, Arizona

Advanced or Metastatic NSCLC

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

📍 AdventHealth — Orlando, Florida

Extensive Stage Small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska

Low Grade Fallopian Tube Serous Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study of Novel Treatment Combinations in Patients With Lung Cancer

📍 Arizona Oncology Associates,Substudy-02 — Tucson, Arizona

Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer

📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts

Prostate Cancer

View Study & Checklist ➔